This patient has class III heart failure with an ejection fraction of 28% and was recently hospitalized for decompensated heart failure. She has been adherent to guideline directed medical therapy including diuretics, beta blockers, ACE inhibitors, and has a cardiac resynchronization device. Given her recent hospitalization and high BNP, adding an aldosterone inhibitor would be a reasonable next step to further optimize her medical management.
Beta Blockers in current cardiovascular practice Praveen Nagula
betablockers are the drug of choice for prevention of progression of heart failure with mortality benefit, after the evolution of neurohormonal regulation as pathogenesis of heart failure
Beta Blockers in current cardiovascular practice Praveen Nagula
betablockers are the drug of choice for prevention of progression of heart failure with mortality benefit, after the evolution of neurohormonal regulation as pathogenesis of heart failure
Aortic stenosis is a valvular heart disease resulting in reduction of blood flow to the body and making the heart work harder. The heart may weaken causing chest pain, fatigue and shortness of breath.
DIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUMPraveen Nagula
DIABETES IS ONE OF THE MOST COMMON NONCOMMUNICABLE DISEASES WORLD WIDE.
EVERY 6 SECONDS ONE PERSON IS AFFECTED BY DIABETES..
THEME FOR 2014-2016
LETS UNITE FOR DIABETES
La Dra. Ainara Lozano Bahamonde repasa las novedades incluidas en las últimas guías europeas en insuficiencia cardiaca presentadas en ESC Congress 2021.
Aortic stenosis is a valvular heart disease resulting in reduction of blood flow to the body and making the heart work harder. The heart may weaken causing chest pain, fatigue and shortness of breath.
DIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUMPraveen Nagula
DIABETES IS ONE OF THE MOST COMMON NONCOMMUNICABLE DISEASES WORLD WIDE.
EVERY 6 SECONDS ONE PERSON IS AFFECTED BY DIABETES..
THEME FOR 2014-2016
LETS UNITE FOR DIABETES
La Dra. Ainara Lozano Bahamonde repasa las novedades incluidas en las últimas guías europeas en insuficiencia cardiaca presentadas en ESC Congress 2021.
In this ppt i am going to discuss various spotters, including ECG, X-ray, fluroscopy images and there answers. These spotter now days asked in various DM cardiology exam conducted all over India, so it will help you in your DM Cardiology exam preperationn.
Diabetes in surgery (evidence based management protocol)Hriday Ranjan Roy
25% diabetic patient need surgery. He or she may have surgical disease along with diabetes or diabetes may complicate to surgical conditions. So it is critical to manage diabetes during surgical events.
Case Presentation in SOAP format on Ischemic Heart Disease with Acute Coronar...Umme Habeeba A Pathan
Heart diseases are major reason for mortality and morbidity. This is the case on how depression and stress can lead to Heart disease and worsen the QOL of patient. Little changes in food style and your attitude towards your health can save your heart.
Dr Ashling Lillis, National Director's Clinical Fellow Macmillan Support, final year trainee in Acute Oncology
Dr Clare Philliskirk, Trainee in Acute Medicine, West Midlands
Dr Sarbit Clare, Acute Medical Consultant, Sandwell and West Birmingham Hospitals
Possible causes of death (Multiorgan failure)
VT/VF intraoperatively
Acute on chronic Heart failur
Respiratory failure
Acute Liver failure
Acute renal failure
Sepsis with septic shock
Concern for Intestinal infarction
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
2. Physical examination of a patient's
cardiovascular system
1.Introduce yourself. position pt.optimal exposure
2.cyanosis/clubbing
splinter hemorrhages
pallor
3.Pulse rate/rhythm, respiratory rate
4.BP lying and standing
5. JVP: height and waveform
carotid pulse:quality, bruits
6. central cyanosis
dental caries
conjunctival pallor
7.Precordial inspection: shape of chest, abnormal pulsation
8.Palpation: site/quality of apex beat, heaves/thrills
3. Physical examination continued
9. Listen to apex, axilla, LSE, LLSE
10. Sit patient forward- feel for parasternal thrill
Listen during inspiration and expiration
11. Palpate thyroid
sacral edema/basal lung dullness
auscultate lungfields for rales
12. Lie patient flat
Pulsatile hepatomegaly
splenomegaly; ascites
Bruits: renal, femoral
13. calf tenderness
ankle edema, tendon xanthomas, peripheral pulses
4. Heart Failure
HTN
CAD
Arrhthymia- A Fib, V fib, SVT
Valvular Heart Disease
Infective endocarditis
Cardiac clearance/Risk
assessment
The heart in other diseases
5. Case1
• 51yo man w dilated cardiomyopathy
whom you have been treating for the past
3 years has class II NYHA heart failure.
Cor angio showed normal coronary
arteries. He would like to be more active
and asks if anything else can be tried.
Takes metop 100mg/d, resting HR
58bpm. Never been able to tolerate ACEI
or ARB developing a severe cough in
multiple previous trials of these agents.
Denies peripheral edema, orthopnea, or
6. Meds and Findings
• Metop 100mg/d
• Furosemide 20mg/d
• Eplerenone 50mg/d
• Digoxin 0.125mg/d
• ECG- nsr w PR interval 147ms and QRS interval
of 98ms
• Echo-LVEF 42%, no sig valve dz, dilated LV w
global hypokinesis
• Exam- JVP 8cm, BP 137/76, HR 58, lungs clear,
no peripheral edema
• Cardiac exam-+s3,1/6 systolic murmur at LLSB
that decreases w Valsalva, enlarged & sustained
point of maximal impulse
7. Which one of the following is the most reasonable
next step in management?
• Prescribe a statin- rosuvastatin 5mg/d
• Refer him to a cardiologist for evaluation
for an AICD
• Refer him to a cardiologist to be evaluated
for cardiac resynchronization therapy
• Initiate treatment w hydralazine and long
acting nitrates
• Increase furosemide to 80mg/d
8. Case 2
• 76 yo man presents w SOB on exertion
that began 6mo ago and has gradually
worsened. Can no longer perform normal
activities wo developing sym and that
climbing one flight of stairs causes him to
be profoundly SOB. Walking on level
ground, he does well, but any hill causes
dyspnea. H/O HTN but no h/o HL, T2D,
tobacco abuse or F/H/O early CAD. On no
meds
9. Findings
• ECG- NSR w normal intervals
• CXR -normal cardiac silhouette w clear
lung fields
• Echo- LVEF 64% w normal valves, N LV,
RV size and function, no regional wall
motion abnormality, normal wall thickness
• Stress test- ability to walk for 4.8 min on
Bruce Protocol (78% of predicted
functional aerobic capacity), HR incr to
146, BP 200/98, stopped test due to SOB,
neg ECG for ischemia
• Exam- lungs clear, JVP 12cm, peripheral
edema 1+, BMI 32
10. Which one of the following actions is
the least appropriate to this patient?
• Initiate treatment w ACEI for BP
• Initiate treatment w diuretic to resolve
congestion and peripheral edema
• Recommend a regular exercise program,
telling him to start slow and increase
gradually
• Encourage him to lose weight
• Refer him for cor angiography
11. Case 3
• 66 yo woman w known CAD has had 2
previous MIs, the first 7 years ago & the
second 11mos ago. After her last MI, her
EF was 28%. Currently has class II NYHA
heart failure
• Meds- lisinopril 40mg/d; carvidelol 12.5mg
BID; spironolactone 25mg/d; ASA 81mg/d;
pravastatin 20mg/d
12. Findings
• Labs- Na 138, K4.4, creat 1.2
• Echo- EF 32% w mild MR, markedly enlarged LV
w anterior wall hypokinesis
• ECG- HR 60 w SR, PR interval 168 ms, QRS
interval 111 ms, corrected QT interval 402 ms,
prior ant MI
• Exam- BP 116/72, HR 60 reg, JVP flat, no
peripheral edema, lungs clear w good BS
• Cardiac exam- presence of S3 w enlarged point
of maximal impulse that is bifid, no murmur or
rub
13. Which one of the following would be the best
therapy for this patient?
• Given that she has NYHA class II HF,
continue current therapy
• Add in a diuretic agent such as
furosemide 20mg/d
• Add in digoxin 0.125mg every 6hours for 4
times, 0.125 mg /d orally
• Refer for cardiac resynchronization
therapy
• Refer for evaluation for an AICD
14. Case 4
• 68 yo man follows up w you after a
hospitalization 2 weeks previously for an
episode of acute decompensated HF.
During his hospitalization, he underwent
diuresis w IV lasix to lose 10lbs of fluid, he
has decreased LV function thought to be
secy to chronic MR. His MV had been
repaired 2 years ago, but his EF of 42%
has not improved significantly since then.
He has a dilated LV and has sym c/w
NYHA class II HF
15. Meds and Findings
• Meds- lasix 20 mg/d; metop 25mg/d;
lisiopril 10mg qhs
• Labs- creat 1.4, e GFR 46, K 4.5, clear
lung fields w enlarged cardiac shadow on
CXR
• Exam- height 177cm, weight 99kg, BP
118/76, HR 62, both lung bases clear, no
leg edema
• Cardiac exam- enlarged bifid; lateral point
of maximal impulse, 1/6 holosystolic
murmur at apex, pos S3, no S4, JVP 8cm
16. Which one of the following is the next best
step in the treatment of this patient?
• Increase lisinopril to 20mg/d
• Add 30 mg of ISMN in am and increase to 60
mg as tolerated
• Refer to a dietitian for a low-sodium, fluid
restricted (1500mL) diet
• Request that he weigh himself each morning,
provide a schedule for increasing lasix if he
gains weight
• Refer him to an electrophysiologist for
possible AICD implantation
17. Case 5
• A 73 yo woman w LV systolic dysfunction
whom you have been treating for several
years presents to the ED. She is having
palpitations and is diagnosed as having A
fib HR 130 in the ED. She denies chest
pain but is mildly SOB w RVR. She is not
sure how long she has had palpitations-
thinks they have been intermittent during
past few months but have always resolved
after a few minutes. This episode lasted
more that 2 h, prompting her to seek
treatment.
18. Medical History
• HTN well controlled w HCTZ
• Hypothyroidism treated medically with normal
TSH
• No h/o bleeding problems, strokes or TIAs
• No syncope or presyncope
• Known CAD w 3-vessel CABG graft performed
11y ago
• Meds- HCTZ 25mg/d; lisinopril 20mg/d; metop
12.5mg/d, ASA 81 mg/d
• Social history- not physically active, lives in a
high rise retirement complex
19. Findings
• Labs- TSH normal, electrolytes normal,
cbc normal, troponin normal
• ECG- A fib, old inferolateral MI, no acute
ST-T changes
• Echo- bilateral atrial enlargement w
enlarged LV and decreased function, EF
34%, evidence of inferolateral MI
• Exam- height 167cm, weight 63 kg, lungs
clear, rhythm irreg irreg, 1/6 systolic
ejection murmur at LLSB, no edema
20. Which one of the following is the best therapy for
this woman w systolic LV dysfunction presenting
w A Fib?
• Control HR w beta-blockers and/or dig &
provide anticoagulation w warfarin to INR
2-3
• Administer antiarrhythmic propofenone &
perform DC cardioversion
• Administer propofenone, perform TEE to
r/o LA thrombus & perform DC
cardioversion
• Refer to EP for consideration of AV node
ablation w pacemaker implantation & long
term anticoagulation
• Refer to EP for pulmonary vein isolation
21. Case 6
• A 78 yo woman who you have been treating for the
past 10 y for ch functional NYHA classIII HF, EF
28%, was admitted to the hospital 3 days ago for
HF. A year earlier she had an AICD/ CRD
implanted. Since being admitted, she has
undergone diuresis, lost 8lbs and feels much
better. You are ready to dismiss her today, w
instructions to continue on her usual home
regimen- lasix 20, carvedilol 25mg BID, lisinopril
20mg qhs. She weighs herself daily & takes extra
lasix & K when her weight increases. She has
been adhering to a low NA diet w 1500ml fluid
restriction. Her BNP is 2186. the cause of her HF
is CAD, but her last stress test 4mos ago showed
a fixed anterior defect but no evidence of ischemia.
22. Which one of the following would be the best
treatment option for this patient at this point in her
care?
• Continuation of current therapy
• Addition of an aldosterone inhibitor, such
as spironolactone or eplerenone
• Augmentation of current therapy to reduce
her BNP levels to normal and her
functional status to NYHA classII or less
• Switch from carvedilol to metoprolol
• Follow up stress test